Evidence map›Paper›PMID 39378853›Full record

ArticleHormone research in paediatrics2026

Genetic Analyses in a Cohort of Pediatric Patients with Congenital Hypothyroidism Based on Congenital Hypothyroidism Consensus Guideline.

Erdal Kurnaz, Ayberk Türkyılmaz, Oğuzhan Yaralı, Ayşe Sena Dönmez, Atilla Çayır

Abstract read
In one paragraph

Article in Hormone research in paediatrics, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Genetic screening and functional characterization ofJournal of the Endocrine Society · 2026
    Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Erdal KurnazDepartment of Pediatric Endocrinology, Etlik City Hospital, University of Health Sciences, Ankara, Turkey, erdalkurnaz44@gmail.com.
Ayberk TürkyılmazDepartment of Medical Genetics, Faculty of Medicine, Karadeniz Technical University, Trabzon, Turkey.
Oğuzhan YaralıDepartment of Medical Genetics, Erzurum City Hospital, Erzurum, Turkey.
Ayşe Sena DönmezDepartment of Pediatrics, Erzurum City Hospital, Erzurum, Turkey.
Atilla ÇayırDepartment of Pediatric Endocrinology, Erzurum City Hospital, University of Health Sciences, Erzurum, Turkey.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

introductionPathogenic variants in the genes involved in the formation of thyroid tissue and thyroid hormone secretion have been reported to cause congenital hypothyroidism (CH) in some cases. This study aimed to evaluate the clinical and genetic findings of CH cases thought to be due to genetic variants.

methodsThe study included cases whose genetic analysis was performed in accordance with the Congenital Hypothyroidism: A 2020-2021 Consensus Guidelines Update Guidelines recommendations criteria and analyzed them using the next-generation sequencing panel.

resultsSixty one Turkish patients from 45 families were included in the study. The overall frequency of variant detection was 37.7% (out of 45 families, 17 had a positive mutation). Segregation was carried out for all families with positive variants. Variants in the TPO gene are the most frequently encountered, and this situation was identified in 10 families. Variants followed this in the TSHR gene in 7 families, variants in the DUOX2 gene in 5 families, and two variants in the TG and NKX2-1 genes in 2 families each, which are six novel variants. Furthermore, among the NKX2-1 cases, one had thyroid involvement only, while the other had chorea only. We did not find differences between cases with detected mutations and mutation-negative cases regarding gender, neonatal/perinatal parameters, initial thyroid function values, and thyroid morphology.

conclusionIn the current investigation, rare new variations in genes known to be related to CH were discovered, adding to the molecular genetic spectrum. When we compare the overall variant detection frequency, the selection criterion for genetic analysis based on the current guidelines is quite rational, considering the benefits and costs, on the other hand, present in new genes awaiting discovery. Also, TSHR mutations are likely to be common and may account for more than 5% of thyroid dysgenesis cases if we include nonfamilial thyroid dysgenesis.

Indexed as

AutoantigensCongenital HypothyroidismDual OxidasesGenetic TestingMutationReceptors, ThyrotropinThyroglobulinThyroid Nuclear Factor 1ChildChild, PreschoolCohort StudiesFemaleHumansInfantInfant, NewbornIodide PeroxidaseAutoantigensDual OxidasesDUOX2 protein, humanIodide PeroxidaseIron-Binding ProteinsNKX2-1 protein, humanReceptors, ThyrotropinTG protein, humanThyroglobulinThyroid Nuclear Factor 1TPO protein, humanTSHR protein, humanCongenital hypothyroidismGene mutation analysisNKX2-1-related disordersThyroid dysgenesisThyroid dyshormonogenesis

Identifiers

PMID39378853
PMCPMC12795535

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.